These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 25751824)
21. Fumagillin inhibits colorectal cancer growth and metastasis in mice: in vivo and in vitro study of anti-angiogenesis. Hou L; Mori D; Takase Y; Meihua P; Kai K; Tokunaga O Pathol Int; 2009 Jul; 59(7):448-61. PubMed ID: 19563408 [TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and evaluation of a cellular stable and detectable biotinylated fumagillin probe and investigation of cell permeability of fumagillin and its analogs to endothelial and cancer cells. Zhou GC; Liu F; Wan J; Wang J; Wang D; Wei P; Ouyang P Eur J Med Chem; 2013; 70():631-9. PubMed ID: 24211639 [TBL] [Abstract][Full Text] [Related]
23. Spiroepoxytriazoles Are Fumagillin-like Irreversible Inhibitors of MetAP2 with Potent Cellular Activity. Morgen M; Jöst C; Malz M; Janowski R; Niessing D; Klein CD; Gunkel N; Miller AK ACS Chem Biol; 2016 Apr; 11(4):1001-11. PubMed ID: 26686773 [TBL] [Abstract][Full Text] [Related]
24. Angiogenesis inhibition as a therapeutic approach for inflammatory synovitis. Lainer-Carr D; Brahn E Nat Clin Pract Rheumatol; 2007 Aug; 3(8):434-42. PubMed ID: 17664950 [TBL] [Abstract][Full Text] [Related]
25. Carbon and nitrogen source nutrition of fumagillin biosynthesis by Aspergillus fumigatus. Yang W; Kim WS; Fang A; Demain AL Curr Microbiol; 2003 Apr; 46(4):275-9. PubMed ID: 12732977 [TBL] [Abstract][Full Text] [Related]
26. Fumagiringillin, a new fumagillin derivative from a strain of the fungus Aspergillus fumigatus. Jiao W; Blunt JW; Cole AL; Munro MH J Nat Prod; 2004 Aug; 67(8):1434-7. PubMed ID: 15332872 [TBL] [Abstract][Full Text] [Related]
27. Design and synthesis of highly potent fumagillin analogues from homology modeling for a human MetAP-2. Han CK; Ahn SK; Choi NS; Hong RK; Moon SK; Chun HS; Lee SJ; Kim JW; Hong CI; Kim D; Yoon JH; No KT Bioorg Med Chem Lett; 2000 Jan; 10(1):39-43. PubMed ID: 10636239 [TBL] [Abstract][Full Text] [Related]
28. FGFR1/PI3K/AKT signaling pathway is a novel target for antiangiogenic effects of the cancer drug fumagillin (TNP-470). Chen GJ; Weylie B; Hu C; Zhu J; Forough R J Cell Biochem; 2007 Aug; 101(6):1492-504. PubMed ID: 17295210 [TBL] [Abstract][Full Text] [Related]
29. Effects of carboxymethylcellulose and carboxypolymethylene on morphology of Aspergillus fumigatus NRRL 2346 and fumagillin production. Yang W; Hartwieg EA; Fang A; Demain AL Curr Microbiol; 2003 Jan; 46(1):24-7. PubMed ID: 12432459 [TBL] [Abstract][Full Text] [Related]
30. A phase I pharmacokinetic and pharmacodynamic study of CKD-732, an antiangiogenic agent, in patients with refractory solid cancer. Shin SJ; Jeung HC; Ahn JB; Rha SY; Roh JK; Park KS; Kim DH; Kim C; Chung HC Invest New Drugs; 2010 Oct; 28(5):650-8. PubMed ID: 19585083 [TBL] [Abstract][Full Text] [Related]
31. Fumagillin, a potent angiogenesis inhibitor, induces Kaposi sarcoma-associated herpesvirus replication in primary effusion lymphoma cells. Kanno T; Uehara T; Osawa M; Fukumoto H; Mine S; Ueda K; Hasegawa H; Katano H Biochem Biophys Res Commun; 2015 Aug; 463(4):1267-72. PubMed ID: 26093300 [TBL] [Abstract][Full Text] [Related]
32. Fumagalone, a reversible inhibitor of type 2 methionine aminopeptidase and angiogenesis. Zhou G; Tsai CW; Liu JO J Med Chem; 2003 Jul; 46(16):3452-4. PubMed ID: 12877582 [TBL] [Abstract][Full Text] [Related]
34. Syntheses of fumagillin and ovalicin. Yamaguchi J; Hayashi Y Chemistry; 2010 Apr; 16(13):3884-901. PubMed ID: 20209516 [TBL] [Abstract][Full Text] [Related]
35. Investigational drugs in Phase II clinical trials for the treatment of obesity: implications for future development of novel therapies. Jackson VM; Price DA; Carpino PA Expert Opin Investig Drugs; 2014 Aug; 23(8):1055-66. PubMed ID: 25000213 [TBL] [Abstract][Full Text] [Related]
36. Fumagillin, a new P-glycoprotein-interfering agent able to modulate moxidectin efflux in rat hepatocytes. Dupuy J; Lespine A; Sutra JF; Alvinerie M J Vet Pharmacol Ther; 2006 Dec; 29(6):489-94. PubMed ID: 17083452 [TBL] [Abstract][Full Text] [Related]
37. [Light- and temperature-induced degradation of fumagillin]. Agner G; Gyórbíró A; Valkó I; Vasvári-Debreczy L; Szabó A; Farkas G; Halász J; Podányi B; Brlik J; Simon K; Hermecz I Acta Pharm Hung; 2003; 73(1):41-5. PubMed ID: 12891898 [TBL] [Abstract][Full Text] [Related]
38. Fumagillin, an antibiotic from Aspergillus funigatus H-3. EBLE TE; HANSON FR Antibiot Chemother (Northfield); 1951 Apr; 1(1):54-8. PubMed ID: 24540610 [No Abstract] [Full Text] [Related]
39. Anti-angiogenic drug loaded liposomes: Nanotherapy for early atherosclerotic lesions in mice. Pont I; Calatayud-Pascual A; López-Castellano A; Albelda EP; García-España E; Martí-Bonmatí L; Frias JC; Albelda MT PLoS One; 2018; 13(1):e0190540. PubMed ID: 29338009 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and antiproliferative activity of ligerin and new fumagillin analogs against osteosarcoma. Blanchet E; Vansteelandt M; Le Bot R; Egorov M; Guitton Y; Pouchus YF; Grovel O Eur J Med Chem; 2014 May; 79():244-50. PubMed ID: 24742383 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]